$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Monoclonal antibodies directed to the HER2 receptor 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-039/395
  • A61K-039/00
  • C07K-016/30
  • C07K-016/46
  • C12P-021/08
출원번호 US-0152654 (1998-09-14)
발명자 / 주소
  • Robert M. Hudziak
  • H. Michael Shepard
  • Axel Ullrich
  • Brian M. Fendly
출원인 / 주소
  • Genentech, Inc.
대리인 / 주소
    Wendy M. Lee
인용정보 피인용 횟수 : 99  인용 특허 : 31

초록 ▼

A method of inhibiting growth of tumor cells which overexpress a growth factor receptor or growth factor by treatment of the cells with antibodies which inhibit the growth factor receptor function, is disclosed. A method of treating tumor cells with antibodies which inhibit growth factor receptor fu

대표청구항 ▼

1. A method of inhibiting the growth of tumor cells that overexpress HER2 receptor comprising administering to a patient an antibody comprising an antigen binding region which specifically binds to an extracellular domain of the HER2 receptor in an amount effective to inhibit growth of the tumor cel

이 특허에 인용된 특허 (31) 인용/피인용 타임라인 분석

  1. Shawver Laura K. ; Brandis John W. ; Mann Elaina ; Hancock Miriam E. C. ; Mischak Ronald P. ; Monahan John J., Anti-neoplastic drugs in cancer therapy.
    상세보기
  2. Ring David B., Antigen-binding sites of antibody molecules specific for cancer antigens.
    상세보기
  3. Carney Walter P. (North Andover MA) McKenzie Sara J. (Lynn MA), Detection and quantification of neu related proteins in the biological fluids of humans.
    상세보기
  4. Carney, Walter P.; McKenzie, Sara J.; Weinberg, Robert A., Detection of neu p185 in cell lysates.
    상세보기
  5. Bargmann Cornelia I. (Arlington MA) Weinberg Robert A. (Brookline MA), Detection of point mutations in neu genes.
    상세보기
  6. Slamon Dennis J. (Woodland Hills CA) McGuire William L. (San Antonio TX), Determination of status in neoplastic disease.
    상세보기
  7. Hudziak Robert Michael ; Shepard H. Michael ; Ullrich Axel,DEX, HER2 extracellular domain.
    상세보기
  8. Marks James D. ; Schier Robert, High affinity human antibodies to tumor antigens.
    상세보기
  9. Mendelsohn John (La Jolla CA) Kawamoto Tomoyuki (Hiroshima NY JPX) Sato Gordon (Lake Placid NY) Sato J. Denry (Duarte CA), Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor.
    상세보기
  10. Hudziak Robert M. ; Ullrich Axel ; Fendly Brian M., In vivo tumor detection assay.
    상세보기
  11. Landucci Gary R. (216 Saybrook Ct. Costa Mesa CA 92627) Mariani Toni N. (1924 E. River Ter. Minneapolis MN 55414), Lymphokine activated effector cells for antibody-dependent cellular cytotoxicity (ADCC) treatment of cancer and other di.
    상세보기
  12. Honn Kenneth V. (Grosse Pointe Woods MI) Taylor John D. (Detroit MI) Onoda James M. (Royal Oak MI), Method and composition for the treatment of tumors by administering a platinum coordination compound and a calcium chann.
    상세보기
  13. Bacus Sarah S. (Hinsdale IL), Method for prognosticating response to cancer therapy.
    상세보기
  14. Herlyn Meenhard (Wynnwood PA) Rodeck Ulrich (Philadelphia PA), Method of treating human EGF receptor-expressing gliomas using radiolabeled EGF receptor-specific MAB 425.
    상세보기
  15. Cline Martin J. (Pacific Palisades CA) Slamon Dennis J. (Woodland Hills CA), Methods and compositions for detecting human tumors.
    상세보기
  16. Frankel Arthur E. (Durham NC) Ring David B. (Redwood City CA) Laird Walter (Pinole CA), Monoclonal anti-human breast cancer antibodies.
    상세보기
  17. Frankel Arthur E. (Palo Alto CA) Ring David B. (Redwood City CA) Bjorn Michael J. (Hercules CA), Monoclonal anti-human breast cancer antibodies.
    상세보기
  18. Hudziak Robert M. (Corvallis OR) Shepard H. Michael (Rancho Santa Fe CA) Ullrich Axel (Portola Valley CA) Fendly Brian M. (Half Moon Bay CA), Monoclonal antibodies directed to the HER2 receptor.
    상세보기
  19. Hudziak Robert M. ; Shepard H. Michael ; Ullrich Axel ; Fendly Brian M., Monoclonal antibodies directed to the HER2 receptor.
    상세보기
  20. Hudziak Robert M. ; Shepard H. Michael ; Ullrich Axel ; Fendly Brian M., Monoclonal antibodies directed to the HER2 receptor.
    상세보기
  21. Hudziak Robert M. ; Shepard H. Michael ; Ullrich Axel ; Fendly Brian M., Monoclonal antibodies directed to the HER2 receptor.
    상세보기
  22. Hudziak Robert M. ; Ullrich Axel ; Fendly Brian M., Monoclonal antibodies directed to the HER2 receptor.
    상세보기
  23. Hudziak Robert M. ; Shepard H. Michael ; Ullrich Axel ; Fendly Brian M., Monoclonal antibodies directed to the her2 receptor.
    상세보기
  24. Schlessinger Joseph ; Givol David,ILX ; Bellot Francoise,FRX ; Kris Richard ; Ricca George A. ; Cheadle Christopher ; South Victoria J., Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same.
    상세보기
  25. King C. Richter ; Kraus Matthias H. ; Aaronson Stuart A., Protein related to but distinct from EGF receptor and antibodies reactive therewith.
    상세보기
  26. Rokugawa Kyuji (Nishinasuno JPX) Hatoh Masako (Yokohama JPX) Ishimori Yoshio (Tokyo JPX), Quantitative immunoassay utilizing liposomes.
    상세보기
  27. Huang Leaf (Knoxville TN), Target-sensitive immunoliposomes- preparation and characterization.
    상세보기
  28. Thorpe Philip E. ; King Steven W. ; Gao Boning, Tissue factor methods and compositions for coagulation and tumor treatment.
    상세보기
  29. Greene Mark I. ; Drebin Jeffrey A., Treatment of tumors with monoclonal antibodies against oncogene antigens.
    상세보기
  30. Shepard H. Michael (San Francisco CA) Talmadge James E. (Frederick MD), Use of tumor necrosis factor (TNF) as an adjuvant.
    상세보기
  31. King C. Richter ; Kraus Matthias H. ; Aaronson Stuart A., erbB-2 gene segments, probes, recombinant DNA and kits for detection.
    상세보기

이 특허를 인용한 특허 (99) 인용/피인용 타임라인 분석

  1. Daugherty, Patrick Sean; Stagliano, Nancy; Thomas, Jerry; Kamath, Kathryn; West, James W.; Khare, Sanjay; Sagert, Jason, Activatable binding polypeptides and methods of identification and use thereof.
    상세보기
  2. Daugherty, Patrick Sean; Stagliano, Nancy; Thomas, Jerry; Kamath, Kathryn; West, James W.; Khare, Sanjay; Sagert, Jason, Activatable binding polypeptides and methods of identification and use thereof.
    상세보기
  3. Daugherty, Patrick Sean; Stagliano, Nancy; Thomas, Jerry; Kamath, Kathryn; West, James W.; Khare, Sanjay; Sagert, Jason, Activatable binding polypeptides and methods of identification and use thereof.
    상세보기
  4. Daugherty, Patrick Sean; Stagliano, Nancy; Thomas, Jerry; West, James W.; Sagert, Jason, Activatable binding polypeptides and methods of identification and use thereof.
    상세보기
  5. Daugherty, Patrick; Stagliano, Nancy; Thomas, Jerry; Kamath, Kathryn; West, James W.; Khare, Sanjay; Sagert, Jason, Activatable binding polypeptides and methods of identification and use thereof.
    상세보기
  6. Bryant, John L., Adjuvant therapy with an anti-ERBB2 antibody conjugated to a maytansiniod.
    상세보기
  7. Roschke, Viktor; Lafleur, David; Hilbert, David M.; Kiener, Peter, Ang-2-binding modular recognition domain complexes and pharmaceutical compositions thereof.
    상세보기
  8. Stagliano, Nancy Elizabeth; West, James William; Kamath, Kathryn; Bessette, Paul Henry; Gluck, Fred; Sagert, Jason Gary; Daugherty, Patrick, Anti-EGFR activatable antibodies.
    상세보기
  9. Bryant, John L., Anti-ERBB2 antibody adjuvant therapy.
    상세보기
  10. Fendly,Brian M., Anti-ErbB2 antibodies.
    상세보기
  11. Yayon, Avner; Rom, Eran; Thomassen-Wolf, Elisabeth; Borges, Eric, Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof.
    상세보기
  12. Yayon,Avner; Rom,Eran; Thomassen Wolf,Elisabeth; Borges,Eric, Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof.
    상세보기
  13. Andya, James; Gwee, Shiang C.; Liu, Jun; Shen, Ye, Antibody formulations.
    상세보기
  14. Barbas, III, Carlos F., Antibody targeting through a modular recognition domain.
    상세보기
  15. Arakawa, Tsutomu; Kita, Yoshiko, Antibody-induced apoptosis.
    상세보기
  16. Arakawa, Tsutomu; Kita, Yoshiko, Antibody-induced apoptosis.
    상세보기
  17. Arakawa,Tsutomu; Kita,Yoshiko, Antibody-induced apoptosis.
    상세보기
  18. Zacharchuk, Charles Michael, Antineoplastic combinations containing HKI-272 and vinorelbine.
    상세보기
  19. Zacharchuk, Charles Michael, Antineoplastic combinations containing HKI-272 and vinorelbine.
    상세보기
  20. Zacharchuk, Charles Michael; Quinn, Susan Elizabeth; Wang, Kenneth Kuan-Yuen; Binlich, Florence Marie Helene, Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine.
    상세보기
  21. Sliwkowski, Mark X.; Kelsey, Stephen M., Combination therapy of her expressing tumors.
    상세보기
  22. Mi, Sha; Pepinsky, R. Blake; Graff, Christilyn, Composition comprising antibodies to LINGO or fragments thereof.
    상세보기
  23. Mi, Sha; Pepinsky, R. Blake; Graff, Christilyn, Composition comprising antibodies to LINGO or fragments thereof.
    상세보기
  24. Harris, Reed J.; Motchnik, Paul A., Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof.
    상세보기
  25. Harris, Reed J.; Motchnik, Paul A., Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof.
    상세보기
  26. Clinton, Gail M., Compositions and methods for treating cancer by modulating HER-2 and EGF receptors.
    상세보기
  27. Clinton,Gail M., Compositions and methods for treating cancer by modulating HER-2 and EGF receptors.
    상세보기
  28. Mi, Sha; Pepinsky, R. Blake; Graff, Christilyn, Compositions comprising antibodies to LINGO or fragments thereof.
    상세보기
  29. Mass, Robert D., Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy.
    상세보기
  30. Barbas, III, Carlos F., EFGR antibodies comprising modular recognition domains.
    상세보기
  31. Roschke, Viktor; Lafleur, David; Hilbert, David M.; Kiener, Peter, EGFR-binding modular recognition domains.
    상세보기
  32. Barbas, III, Carlos F., ERBB2 antibodies comprising modular recognition domains.
    상세보기
  33. Derynck, Mika K.; Kelsey, Stephen M., Extending time to disease progression or survival in cancer patients.
    상세보기
  34. Allison, David E.; Bruno, Rene; Lu, Jian-Feng; Ng, Chee M., Fixed dosing of HER antibodies.
    상세보기
  35. Allison,David E.; Bruno,Rene; Lu,Jian Feng; Ng,Chee M., Fixed dosing of HER antibodies.
    상세보기
  36. Vitalis, Timothy Z.; Gabathuler, Reinhard, Fragments of P97 and uses thereof.
    상세보기
  37. Vitalis, Timothy Z.; Gabathuler, Reinhard, Fragments of p97 and uses thereof.
    상세보기
  38. Mass, Robert D., Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy.
    상세보기
  39. Mass, Robert D., Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy.
    상세보기
  40. Mass, Robert D., Gene detection assay for improving the likelihood of an effective response to an EGFR antagonist cancer therapy.
    상세보기
  41. Lee-Hoeflich, Si Tuen; Stern, Howard, Gene expression markers of tumor resistance to HER2 inhibitor treatment.
    상세보기
  42. Clinton, Gail M.; Evans, Adam; Henner, William D., HER-2 binding antagonists.
    상세보기
  43. Doherty,Joni Kristin; Clinton,Gail M.; Adelman,John P., HER-2 binding antagonists.
    상세보기
  44. Kao, Yung Hsiang; Vanderlaan, Martin, HER2 antibody composition.
    상세보기
  45. Kao, Yung-Hsiang; Vanderlaan, Martin, HER2 antibody composition.
    상세보기
  46. Kao, Yung-Hsiang; Vanderlaan, Martin, HER2 antibody composition.
    상세보기
  47. Wicha, Max S.; Korkaya, Hasan, HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells.
    상세보기
  48. Adams, Camellia W.; Presta, Leonard G.; Sliwkowski, Mark, Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies.
    상세보기
  49. Adams, Camellia W.; Presta, Leonard G.; Sliwkowski, Mark, Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies.
    상세보기
  50. Sliwkowski, Mark, Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies.
    상세보기
  51. Rosenblum,Michael G., Immunotoxins directed against CD33 related surface antigens.
    상세보기
  52. Mi, Sha; Pepinsky, R. Blake, LINGO-2 antagonists for treatment of conditions involving motor neurons.
    상세보기
  53. Wang, Xinzhong; Bailly, Veronique; Lugovskoy, Alexey; Farrington, Graham K.; Graff, Christilyn; Glaser, Scott, Light targeting molecules and uses thereof.
    상세보기
  54. Lu, Quinhong; Ku, Mannching Sherry; Chew, Warren; Cheal, Gloria; Hadfield, Anthony F.; Mirmehrabi, Mahmoud, Maleate salts of (E)-N-{4-[3-Chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof.
    상세보기
  55. Lu, Quinhong; Ku, Mannching Sherry; Chew, Warren; Cheal, Gloria; Hadfield, Anthony F.; Mirmehrabi, Mahmoud, Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof.
    상세보기
  56. Lu, Qinghong; Ku, Mannching Sherry; Chew, Warren; Cheal, Gloria; Hadfield, Anthony F.; Mirmehrabi, Mahmoud, Maleate salts of (E)-N-{4[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof.
    상세보기
  57. Clinton, Gail M., Method of treating cancer by inhibition of p95HER-2 production.
    상세보기
  58. Andya, James; Gwee, Shiang C.; Liu, Jun; Shen, Ye, Method of treating cancer with a pharmaceutical formulation comprising a HER2 antibody.
    상세보기
  59. Stagliano, Nancy E.; West, James W.; Kamath, Kathryn; Bessette, Paul H.; Gluck, Fred; Sagert, Jason; Daugherty, Patrick, Modified antibody compositions, methods of making and using thereof.
    상세보기
  60. Stagliano, Nancy E.; West, James W.; Kamath, Kathryn; Bessette, Paul H.; Gluck, Fred; Sagert, Jason; Daugherty, Patrick, Modified antibody compositions, methods of making and using thereof.
    상세보기
  61. Stagliano, Nancy E.; West, James W.; Kamath, Kathryn; Bessette, Paul H.; Gluck, Frederick W.; Sagert, Jason; Daugherty, Patrick, Modified antibody compositions, methods of making and using thereof.
    상세보기
  62. Stagliano, Nancy E.; West, James William; Kamath, Kathryn; Bessette, Paul Henry; Gluck, Fred; Sagert, Jason Gary; Daugherty, Patrick, Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV.
    상세보기
  63. Finn, Richard S.; Dering, Judy; Slamon, Dennis J.; Ginther, Charles L.; Clark, Edwin A., Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers.
    상세보기
  64. Barbas, III, Carlos F., Multispecific antibody targeting and multivalency through modular recognition domains.
    상세보기
  65. Mi, Sha; McCoy, John; Pepinsky, R. Blake; Lee, Daniel H. S., NOGO receptor binding protein.
    상세보기
  66. Mi, Sha; McCoy, John; Pepinsky, R. Blake; Lee, Daniel H. S., NOGO receptor binding protein.
    상세보기
  67. Mi, Sha; McCoy, John; Pepinsky, R. Blake; Lee, Daniel H. S., Nogo receptor binding protein.
    상세보기
  68. Jefferies, Wilfred; Tian, Mei Mei; Vitalis, Timothy, P97 fragments with transfer activity.
    상세보기
  69. Jefferies, Wilfred; Tian, Mei Mei; Vitalis, Timothy, P97 fragments with transfer activity.
    상세보기
  70. Jefferies, Wilfred; Vitalis, Timothy Z.; Gabathuler, Reinhard, P97-antibody conjugates and methods of use.
    상세보기
  71. Vitalis, Timothy Z.; Gabathuler, Reinhard, P97-antibody conjugates and methods of use.
    상세보기
  72. Jefferies, Wilfred; Gabathuler, Reinhard, P97-polynucleotide conjugates.
    상세보기
  73. Gennaro, Lynn A.; Kao, Yung-Hsiang; Zhang, Yonghua, Pertuzumab variants and evaluation thereof.
    상세보기
  74. Gennaro, Lynn A.; Kao, Yung-Hsiang; Zhang, Yonghua, Pertuzumab variants and evaluation thereof.
    상세보기
  75. Roschke, Viktor; Lafleur, David; Hilbert, David M.; Kiener, Peter, Polynucleotides encoding angiopoietin-2 (ang-2) binding polypeptides.
    상세보기
  76. Amler, Lukas C.; Birkner, Merrill; Lin, Chin-Yu; Moecks, Joachim; Strauss, Andreas, Predicting response to a HER inhibitor.
    상세보기
  77. Amler, Lukas C.; Birkner, Merrill; Lin, Chin-Yu; Moecks, Joachim; Strauss, Andreas, Predicting response to a HER inhibitor.
    상세보기
  78. Connelly, Patrick R.; Helfer, Jeffrey L.; Custer, Andrew W.; Kim, Michael B., Process for in vivo treatment of specific biological targets in bodily fluids.
    상세보기
  79. Connelly, Patrick R; Helfer, Jeffrey L; Custer, Andrew W; Kim, Michael B, Process for in vivo treatment of specific biological targets in bodily fluids.
    상세보기
  80. Stagliano, Nancy E.; West, James W.; Kamath, Kathryn; Bessette, Paul H.; Sagert, Jason, Protease activatable interferon alpha proprotein.
    상세보기
  81. Andya, James; Cleland, Jeffrey L.; Hsu, Chung C.; Lam, Xanthe M.; Overcashier, David E.; Shire, Steven J.; Yang, Janet Yu-Feng; Wu, Sylvia Sau-Yan, Protein formulation.
    상세보기
  82. Mi, Sha; Pepinsky, R. Blake; Shao, Zhaohui; Graff, Christilyn, SP35 antibodies and uses thereof.
    상세보기
  83. Mi, Sha; Pepinsky, R. Blake; McCoy, John, Screening methods for identifying Sp35 antagonists.
    상세보기
  84. Stagliano, Nancy E.; West, James W.; Kamath, Kathryn; Bessette, Paul H.; Sagert, Jason G., Soluble notch receptor proproteins and methods of use thereof.
    상세보기
  85. Mi, Sha; Pepinsky, R. Blake; Shao, Zhaohui; Garber, Ellen A.; Miklasz, Steven D.; Graff, Christilyn, Sp35 antibodies and uses thereof.
    상세보기
  86. Mi, Sha; Pepinsky, R. Blake; Shao, Zhaohui; Garber, Ellen A.; Miklasz, Steven D.; Graff, Christilyn, Sp35 antibodies and uses thereof.
    상세보기
  87. Mi, Sha; Pepinsky, R. Blake; Shao, Zhaohui; Graff, Christilyn, Sp35 antibodies and uses thereof.
    상세보기
  88. Berkenblit, Anna; Binlich, Florence Marie Helene; Goss, Paul, Treatment regimen utilizing neratinib for breast cancer.
    상세보기
  89. Hellmann, Susan D., Treatment with anti-ErbB2 antibodies.
    상세보기
  90. Hellmann, Susan D., Treatment with anti-ErbB2 antibodies.
    상세보기
  91. Hellmann, Susan D., Treatment with anti-ErbB2 antibodies.
    상세보기
  92. Hellmann, Susan D., Treatment with anti-ErbB2 antibodies.
    상세보기
  93. Hellmann, Susan D., Treatment with anti-ErbB2 antibodies.
    상세보기
  94. Paton, Virginia E.; Shak, Steven; Hellmann, Susan D., Treatment with anti-ErbB2 antibodies.
    상세보기
  95. Sliwkowski, Mark, Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs.
    상세보기
  96. Adams,Camellia W.; Presta,Leonard G.; Sliwkowski,Mark, Treatment with anti-ErbB2 antibodies and anti-hormonal compounds.
    상세보기
  97. Adams,Camellia W.; Presta,Leonard G.; Sliwkowski,Mark, Treatment with anti-ErbB2 antibodies and chemotherapeutic agents.
    상세보기
  98. Adams,Camellia W.; Presta,Leonard G.; Sliwkowski,Mark, Treatment with anti-ErbB2 antibody combinations.
    상세보기
  99. Barbas, III, Carlos F., VEGF antibodies comprising modular recognition domains.
    상세보기

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 특허

해당 특허가 속한 카테고리에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로